GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,369,992 | -31.5% | 27,593 | -17.8% | 0.00% | -50.0% |
| Q2 2023 | $1,999,413 | +51.6% | 33,581 | +44.2% | 0.00% | +100.0% |
| Q1 2023 | $1,318,636 | +17.1% | 23,281 | +53.6% | 0.00% | 0.0% |
| Q4 2022 | $1,125,710 | +6.3% | 15,157 | +5.6% | 0.00% | +100.0% |
| Q1 2022 | $1,059,000 | +3.3% | 14,358 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $1,025,000 | -6.3% | 14,196 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,094,000 | +5.1% | 14,272 | +6.3% | 0.00% | 0.0% |
| Q2 2021 | $1,041,000 | +60.9% | 13,430 | +28.0% | 0.00% | 0.0% |
| Q1 2021 | $647,000 | +72.5% | 10,494 | +33.5% | 0.00% | – |
| Q2 2020 | $375,000 | -62.6% | 7,862 | -66.7% | 0.00% | -100.0% |
| Q1 2020 | $1,004,000 | -47.2% | 23,604 | -27.0% | 0.00% | -50.0% |
| Q4 2019 | $1,903,000 | +3.3% | 32,314 | -10.3% | 0.00% | 0.0% |
| Q3 2019 | $1,842,000 | -46.3% | 36,019 | -55.6% | 0.00% | -33.3% |
| Q2 2019 | $3,433,000 | -68.9% | 81,174 | -63.6% | 0.00% | -72.7% |
| Q1 2019 | $11,028,000 | -14.2% | 223,191 | -24.9% | 0.01% | -21.4% |
| Q4 2018 | $12,856,000 | -7.4% | 297,038 | +21.5% | 0.01% | +7.7% |
| Q3 2018 | $13,881,000 | +57.8% | 244,553 | +40.3% | 0.01% | +44.4% |
| Q2 2018 | $8,796,000 | +34.6% | 174,310 | +32.8% | 0.01% | +50.0% |
| Q1 2018 | $6,537,000 | +289.3% | 131,209 | +86.3% | 0.01% | +200.0% |
| Q2 2016 | $1,679,000 | -86.8% | 70,445 | -86.8% | 0.00% | -86.7% |
| Q1 2016 | $12,712,000 | -11.1% | 535,252 | +4.2% | 0.02% | -6.2% |
| Q4 2015 | $14,292,000 | -26.6% | 513,701 | -45.5% | 0.02% | -30.4% |
| Q3 2015 | $19,465,000 | -15.3% | 942,164 | +5.3% | 0.02% | -8.0% |
| Q2 2015 | $22,970,000 | -16.8% | 894,830 | -18.2% | 0.02% | -21.9% |
| Q1 2015 | $27,603,000 | +7.2% | 1,093,646 | +1.0% | 0.03% | +10.3% |
| Q4 2014 | $25,748,000 | +99.7% | 1,083,213 | +63.8% | 0.03% | +81.2% |
| Q3 2014 | $12,892,000 | -31.1% | 661,389 | -15.4% | 0.02% | -30.4% |
| Q2 2014 | $18,706,000 | +7.4% | 782,003 | +17.9% | 0.02% | +9.5% |
| Q1 2014 | $17,410,000 | +303.6% | 663,134 | +210.2% | 0.02% | +320.0% |
| Q4 2013 | $4,314,000 | +12.2% | 213,755 | -3.0% | 0.01% | 0.0% |
| Q3 2013 | $3,846,000 | – | 220,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |